Life Sciences Report Collection
The Life Sciences Collection spans markets that are central to the life and wellbeing of the more than 7.5 billion people on our planet. From emerging diagnostics, to brand new therapies and treatment technologies, our expert analysts know where your focus – and investment – should be when it comes to biotechnology, pharmaceuticals and healthcare. As your senior editor, I look forward to introducing you to new opportunities.
These reports emphasize markets where technologies intersect with the building blocks of human life, including DNA, RNA, cancer, genomics, genetics, molecular diagnostics and more.
Globally, healthcare constitutes a multi trillion-dollar industry. Reports in this category span the range of treatments, administration practices and technologies available around the world.
Enormously important intersection of engineering, tissue manipulation, the surgeons scalpel and design. Specialist companies target well known and also the barely pronounceable conditions.
This report provides information on significant drug launches in 2019. The study provides an overview of each drug, scientific summaries, pharmacodynamics, pharmacokinetics and clinical trial information, disease backgrounds, analysis of the market, competitors and company profiles of manufacturers. The objective of this study is to present a comprehensive analysis of the current market and its future direction.
The global digital pathology market should reach $10.2 billion by 2023 from $4.8 billion in 2018 at a compound annual growth rate (CAGR) of 16.5% for the period of 2018 to 2023.
The global viral vector and plasmid DNA technologies market should grow from $500 million in 2019 to over $1.1 billion by 2024 with a compound annual growth rate (CAGR) of 18.0% during the period, 2019-2024.
This report provides a brief description of advanced image-guided surgery (IGS) systems, also known as surgical navigation, and their applications in medicine and dentistry. Recent innovations and current and emerging trends in IGS technology will also be assessed.
The global market for DNA read, write and edit applications should grow from $17.0 billion in 2019 to $43.1 billion by 2024 with a compound annual growth rate (CAGR) of 20.5% during the period of 2019-2024.
The report provides a detailed description of Machine learning (ML) as the branch of artificial intelligence and its possible range of functions. Latest developments and recent achievements in the life sciences due to machine learning will also be assessed.
This report provides a brief description of super-resolution imaging techniques, and evaluates the current and emerging trends related to this technology.
The global market for medical device should grow from $470.5 billion in 2018 to reach $640.9 billion by 2023 at a compound annual growth rate (CAGR) of 6.4% for the period of 2018-2023.
The global market for pharmacy automation should grow from $5.1 billion in 2019 to $7.8 billion by 2024 at a compound annual growth rate (CAGR) of 8.6% for the period of 2019-2024.
The global market for human identification reached $43.0 billion in 2019 and should reach $83.9 billion by 2024, at a compound annual growth rate (CAGR) of 14.3% for the period of 2019-2024.
Consumption of nanostructures in the life science sectors (e.g., nanoparticles, nanospheres, nanocapsules, and quantum dots) is projected to be characterized by healthy growth during the next five years. The report provides a detailed description of applications in the medical sector and examines main drivers for market growth within this industry. The global market for nanostructures in life science should reach $17.8 billion in 2019 and is projected to reach $33.8 billion in 2024, registering a CAGR of 13.7% during the five-year period.
The global market for communicable disease should grow from $57.7 billion in 2019 to $69.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.8% for the period of 2019-2024.
This report presents a perspective on the adoption of continuous manufacturing technologies by pharmaceuticals, the role of the FDA and implications for the generics sector.
The global market for organ-on-a-chip should grow from $11.3 million in 2018 to $60.6 million by 2023 at a compound annual growth rate (CAGR) of 39.9% from 2018 to 2023.
The global single-use technology in the biopharmaceutical market should reach $5.9 billion by 2024 from $3.5 billion in 2019 at a compound annual growth rate (CAGR) of 11.3% for the period of 2019 to 2024.
The global market for point of care (POC) diagnostics and testing should grow from $19.3 billion in 2018 to $25.5 billion by 2023 with a compound annual growth rate (CAGR) of 5.7% from 2018 to 2023.
The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.
This report is intended to inform the reader about 5G wireless and how it works. 5G wireless technology is just beginning to be installed globally, and its impact on healthcare is already beginning to be felt; but experts are convinced that 5G is set to be a disruptive force with respect to healthcare in both developing and developed countries. The report will then discuss the significance of 5G in relation to healthcare systems and how this technology may potentially improve the delivery of personalized care while decreasing healthcare costs.
This report will assess the latest developments that are taking place with regard to the current research and development environment of TILs and explore the novel strategies companies are adopting to identify and enhance TIL selection, biosynthesis and delivery in a wide range of metastatic cancers including, melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumors.
The global market for catheters should grow from $27.2 billion in 2018 to $34.5 billion by 2023 at a compound annual growth rate (CAGR) of 4.8% for the period of 2018-2023.
The global market for GxP/GMP regulation testing services should grow from $8.1 billion in 2019 to reach $14.2 billion by 2024 at a compound annual growth rate (CAGR) of 11.8% for the period of 2019-2024.
The global stem cell and regenerative medicines market should grow from $21.8 billion in 2019 to reach $55.0 billion by 2024 at a compound annual growth rate (CAGR) of 20.4% for the period of 2019-2024.
Just in 2017, medical cannabis totaled $7.3 billion, up from $4.8 billion in 2016. This segment will likely achieve a 22.2% CAGR to reach nearly $19.8 billion at the producer level in 2022 and will account to more than 80% of the global market. Politics aside, one must remember that marijuana is still a drug and needs to be treated as such with its potential side effects. Even if cannabinoids-based drugs will not fully substitute opioid use, combination of medical marijuana use with reduced dose of opioid will help to curb the crisis.
The global market for sensors should grow from $173.4 billion in 2019 to reach $323.3 billion by 2024 at a compound annual growth rate (CAGR) of 13.3% for the period of 2019-2024.
The global market for microbiome sequencing should grow from $885 million in 2018 to $2.0 billion by 2023 at a compound annual growth rate (CAGR) of 18.2% for the period of 2018-2023.
Report will forecast current and future trends in health and weight management space and its potential market for 2020-2025.
Get an outlook on the HTA process and its approvals in major pharma industries.
This report provides an overview of global CRISPR market, discussion on CRISPR interference technique and its potential application in alteration of germline of animal, human and other organisms
Get an overview of the current state of the art for Continuous Glucose Monitoring (CGM) for diabetes.
- An overview of R&D, economic impact and future implications for global market due to COVID-19
- Coverage of therapies which are currently being produced and clinical trials of vaccines for COVID-19
- Insights into key scientific breakthroughs and developments that are underway right now
- Information on scientific studies on previously approved medicines that could treat this infection
The report will provide details about the pain management drugs used in the form of patches for immediate relief from any type of pain.
The current report provides detailed exposure to the sternal closure devices market.
The current report provides detailed competitive landscape of top 100 medical device manufacturers in the global market.
Examine 3D cell cultures technologies with current market status, future market drivers and its growth potential over the five-year period from 2019 to 2024.
This report provides comprehensive analysis of biologics, or biopharmaceuticals, on a global basis. it also gives information, from detailed product analyses within disease subsegments to overall industry trends.
Get a comprehensive view of the global markets for natural language processing (NLP) in healthcare industry.
Get an overview of the global markets for over-the-counter (OTC) drugs, medical devices and diagnostics. Analyses of global market trends with data from 2018 to 2019, and projections of compound annual growth rates (CAGRs) through 2024.
An overview of the global markets for pharmaceuticals, specifically healthcare legislation and regulation, pricing mechanisms, and reimbursement procedures.
This report evaluates the effect of strategic factors such as technology-driven change and industry consolidation on the antifungal drugs market. it also provides information on the current market dynamics and factors influencing the future growth opportunities in the antifungal drugs market.
Get an analysis of the advanced drug delivery market by technology systems, applications, routes of administration, and drug delivery vehicles.
Get an overview of the global markets and technologies for rare disease diagnostics and discussion on market opportunities for these technologies.
Detailed review of artificial intelligence (AI) applications in the diagnosis and treatment of cancer diseases. Coverage of different AI algorithm types -- artificial neural networks and deep learning -- and their feasible healthcare applications in the field of cancer
Get an overview of global market for cell and gene therapy tools and information on their importance in treating human health.
An overview of the artificial intelligence (AI) applications in fighting against HIV/AIDS-related illnesses. Discussion of recent achievements and breakthrough therapies related to HIV/AIDS disease segments.
PCR for POC Diagnostics
BCC Research analyst Todd Graham delves into the markets being served by the new technology for polymerase chain reaction for point-of-care diagnostics, sharing the uses, outlook, and more on these clinical diagnostic kits. Recorded live on May 16, 2018.
How to Dissect a Market Opportunity
BCC Research Senior Editor Gordon Nameni shares how to interpret market research to uncover market opportunities at a live event on September 12, 2017, in Boston, MA.